{"title":"Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis.","authors":"Tian Lan, Yan-Hui Liao, Jian Zhang, Zhi-Ping Yang, Gao-Si Xu, Liang Zhu, Dai-Ming Fan","doi":"10.2147/TCRM.S340587","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF).</p><p><strong>Setting: </strong>A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results.</p><p><strong>Participants: </strong>A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis.</p><p><strong>Primary and secondary outcome measures: </strong>The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality.</p><p><strong>Results: </strong>The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14-0.23) and 0.53 (95% CI 0.46-0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10-0.18) and 0.29 (95% CI 0.25-0.33), respectively. Comorbidities were highly prevalent in individuals with HF.</p><p><strong>Conclusion: </strong>Heart failure hospitalization is followed by high readmission and mortality rates.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/38/tcrm-17-1307.PMC8665875.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S340587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 8
Abstract
Objective: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF).
Setting: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results.
Participants: A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis.
Primary and secondary outcome measures: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality.
Results: The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14-0.23) and 0.53 (95% CI 0.46-0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10-0.18) and 0.29 (95% CI 0.25-0.33), respectively. Comorbidities were highly prevalent in individuals with HF.
Conclusion: Heart failure hospitalization is followed by high readmission and mortality rates.
目的:本研究旨在探讨心力衰竭(HF)后死亡率和再入院率及其危险因素。环境:在PubMed、Cochrane图书馆和EMBASE中进行系统搜索,以确定符合条件的报告。采用随机效应模型对合并结果进行评价。参与者:共有27项研究,515,238名参与者最终进行了meta分析。在合并分析中,HF患者的平均年龄为76.3岁,51%的样本为男性。主要和次要结局指标:结局指标为30天和1年再入院率、死亡率、再入院和死亡率的危险因素。结果:再入院和死亡率的效应量以平均值和95%置信区间(CI)估计。估计30天和1年的全因再入院率分别为0.19 (95% CI 0.14-0.23)和0.53 (95% CI 0.46-0.59),而全因死亡率分别为0.14 (95% CI 0.10-0.18)和0.29 (95% CI 0.25-0.33)。合并症在心衰患者中非常普遍。结论:心力衰竭住院后再入院率高,死亡率高。